The FDA’s Center for Biologics Evaluation and Research (CBER) granted NanoMosaic’s request for an Advanced Manufacturing Technology (AMT) designation for its Nanoneedle technology for multiplex ...
Domestic manufacturing can improve quality oversight by reducing foreign inspection gaps and enabling early FDA engagement ...
Tony Lakavage, executive vice president and head of Global External Affairs at the US Pharmacopeia (USP), outlines the key ...
Beginning January 1, 2026, the company's collagen production will operate out of MPM Medical's 100,000 sq. ft. FDA-registered facility in Mesquite, Texas. The expansion includes advanced collagen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results